Short Term Trading Weekend Lounge : 13 -15 Jan, page-191

Have we got a final Med-Tech full list/summary yet? @UmiTrader

Might be a few eyes on it next week....

My pick CYP almost fits into med-tech  really, not in app or SaaS sense, but it's an enabling tech for commercial manufacture of stem cell therapies, a technology platform for cell expansion.

I'll save it to the Biotech w/end, but I do think there is some crossover with Cynata, as it's not a drug developer, and many probably just lump it in the higher risk/ single breakthrough junior bio basket. I think many have made this mistake before looking into CYP deeper.

It's a patented tech, out of top quality research in US.
Worth a look if you like tech, believe in the stem cell sector revolution, but don't want the higher cash burn of a typical bio.
and I'll add, it has NO ethical dramas, not embryonic

For mine, medical tech breakthroughs and commercialization next decade will be as big as electric cars.
Massive markets and growth.